Abstract
Clinical trials must be conducted in a way which is in line with the primary principle that clinical trial participants’ rights, safety, health, and welfare override the interest of science and society. The subject matter of the present study is an analysis of the provisions of the criminal law concerning clinical trials, in particular Art. 126 a of the Act of 6 September 2001 – Pharmaceutical Law (Dz.U. 2019, Item 499, 399) and Art. 27 of the Criminal Code. In my view, the criminal aspects of pharmaceutical law are not sufficiently stressed in the ongoing scientific discourse.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zeszyty Naukowe Uniwersytetu Rzeszowskiego. Seria Prawnicza. Prawo
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
